The Ministry of Health and Prevention (MOHAP) has confirmed the quality and safety of Brufen, an anti-inflammatory, analgesic and antipyretic medicine registered in the UAE for use in children. There are no warnings against this medicine.
H.E. Dr. Amin Hussein Al Amiri, the Ministry’s Assistant Undersecretary for Public Health Policy and Licensing and Chairman for Supreme National Pharmacovigilance committee, noted that rumours circulated on social media regarding the presence of aluminum particles in Brufen are incorrect. The Ministry has not issued any warnings about the use of Brufen, and has not received any notifications from the US Food and Drug Administration (FDA), the European Medicines Authority (EMA), or the Australian Drug Authority. The Ministry has also made efforts to communicate with the manufacturer of the drug, who reaffirmed that these claims are false.
Brufen, a non-steroidal anti-inflammatory drug, is known scientifically as ibuprofen and is sold over-the-counter as an anti-inflammatory and pain killer, it can be used for pain in teeth, joints and for headaches. It is also antipyretic. Brufen is available as syrup for children and in tablet form in dosages of 200mg, 400mg, and 600mg.
Members of the community are urged to refrain from believing rumours published on social media, and to contact the Ministry of Health & Prevention or relevant health authorities to attain any information regarding medicines, medical warnings and anything else regarding medicines and medical devices in the UAE.